Eli Lilly, buy signal in progress in week 5
Eli Lilly -6.7%: buy signal still 7.17% up in week 5, scaling out next week
Our view last week
Eli Lilly stock gains 6.6%, and the buy signal, now in week 4, is 14.83% up since entry. This week also brings the second of our model's 3 references, after the first was reached last week. For a new entry, the model points to a reduced position size, and the next scaling-out window, for 10% of the position, comes in week 6.
This week's summary
Eli Lilly stock drops 6.7% on the week, yet the buy signal, now in week 5, is still 7.17% up since entry. Our model sees a medium expected move on this signal, and 2 of its 3 references have already been reached. The next scaling-out window comes in week 6, for 10% of the position, while new entries get a full position size.
Disclaimer. Technical analysis and personal opinion of the author, not financial advice or a personalised recommendation. The author may hold positions in the instruments analysed. Read more ▾Close ▴
Disclaimer — The content on this page is published for educational and informational purposes and represents the author's personal opinion and technical analysis. It is not financial advice, a solicitation to invest, or personalised recommendation. Trading financial instruments involves significant risks and may result in the loss of all or part of the invested capital. Every operational decision is the sole responsibility of the user, who acknowledges acting in full autonomy and full awareness of risk. The author may hold, open or close positions in the instruments analysed, including positions opposite to the analysis, before or after publication, with no obligation to disclose them.
restricted Platinum content